Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q1 FY26 results · Apr–Jun 2025
Wockhardt reported revenue from operations of ₹738.00 crore (down 0.1% from Q1 FY25) and net loss of ₹108.00 crore for Q1 FY26 (Apr–Jun 2025), on a consolidated basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 738.00 | 739.00 | −0.1% | 743.00 | −0.7% |
| Other income | 20.00 | 30.00 | −33.3% | 15.00 | +33.3% |
| Total income | 758.00 | 769.00 | −1.4% | 758.00 | +0.0% |
| Profit before tax | (109.00) | (6.00) | Loss widened | (22.00) | Loss widened |
| Net profit for the period | (108.00) | (16.00) | Loss widened | (45.00) | Loss widened |
| Attributable to shareholders of the company | (90.00) | (14.00) | Loss widened | (25.00) | Loss widened |
| EPS, basic (₹) | (5.53) | (0.95) | Loss widened | (1.57) | Loss widened |
| Net margin (%) | -14.6 | -2.2 | -6.1 |
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 413.00 | 352.00 | +17.3% | 355.00 | +16.3% |
| Other income | 25.00 | 27.00 | −7.4% | 14.00 | +78.6% |
| Total income | 438.00 | 379.00 | +15.6% | 369.00 | +18.7% |
| Profit before tax | 69.00 | 6.00 | 12x | 40.00 | +72.5% |
| Net profit for the period | 69.00 | 6.00 | 12x | 40.00 | +72.5% |
| EPS, basic (₹) | 4.25 | 0.39 | +989.7% | 2.47 | +72.1% |
| Net margin (%) | 16.7 | 1.7 | 11.3 |
Consolidated
- Filed with BSE
- 08 Aug 2025, 18:05 IST
- Board meeting
- 08 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Aug 2025, 18:05 IST
- Board meeting
- 08 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE